RXRX 4.88 ▲ 1.46% Live Trading Data - Stocknear

Recursion Pharmaceuticals...

NASDAQ: RXRX · Real-Time Price · USD
4.88
0.07 (1.46%)
At close: Sep 24, 2025, 3:59 PM
4.93
1.02%
After-hours: Sep 24, 2025, 07:59 PM EDT
1.46%
Bid 4.87
Market Cap 2.1B
Revenue (ttm) 64.44M
Net Income (ttm) -648.97M
EPS (ttm) -1.81
PE Ratio (ttm) -2.7
Forward PE -3.89
Analyst Hold
Dividends n/a
Ask 4.89
Volume 41,691,240
Avg. Volume (20D) 24,698,988
Open 4.88
Previous Close 4.81
Day's Range 4.83 - 5.17
52-Week Range 3.79 - 12.36
Beta 0.91
Ex-Dividend Date n/a

About RXRX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RXRX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for RXRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
Recursion Pharmaceuticals Inc. is scheduled to release its earnings on Nov 5, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-4.66%
Recursion Pharmaceuticals shares are trading lower... Unlock content with Pro Subscription
2 months ago
+8.72%
Recursion Pharmaceuticals shares are trading higher after the company announced it acquired the joint ENPP1 inhibitor program and associated backup molecule from Rallybio.